Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer

1 Oct 2016

Abstract excerpt

BACKGROUND: In recent years, CD44 and CD133 have been identified as 2 common used cancer stem cell (CSC) markers in gastric cancer. However, the clinicopathological and prognostic value of these markers in gastric cancer remains controversial; moreover, there is lack of comparison of these 2 markers' roles in clinical applications. A systematic review and meta-analysis was conducted to elucidate these markers'...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Gastric Cancer Management and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27759647
DOI: 10.1097/md.0000000000005163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancerPMID 27759647Read ↗

Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.Semantic proximity Read ↗

Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.Semantic proximity Read ↗

Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44Semantic proximity Read ↗

Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic InsightsSemantic proximity Read ↗

CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant featuresSemantic proximity Read ↗

Analysis of the prognostic biomarkers associated with cancer stem cell characteristics and immune infiltration of Helicobacter pylori-induced gastric cancerSemantic proximity Read ↗

Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profilingSemantic proximity Read ↗

Cancer stem cells in human digestive tract malignancies.Semantic proximity Read ↗

CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem CellsSemantic proximity Read ↗

New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulationSemantic proximity Read ↗

Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysisSemantic proximity Read ↗

Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.